Pancreatic Cancer Research

ResearcherYamaguchi UniversityActive in the last 2 years

Masao Nakajima

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5889-2350; OpenAlex author ID A5001958420, A5089661404, A5102959132. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 4 papers · 2025: 1 paper · 2026: 2 papers

Papers 11

  1. Reconsidering upfront surgery for resectable pancreatic ductal adenocarcinoma: The role of risk stratification and neoadjuvant chemotherapy. Co-author DOI 10.1016/j.suronc.2025.102333↗
  2. Immature Peritumoral Tertiary Lymphoid Structures Indicate Poor Prognosis in Pancreatic Ductal Adenocarcinoma After NAC. First author DOI 10.21873/anticanres.18061↗
  3. Survival Analysis of 4 Different Age Groups of Pancreatic Ductal Adenocarcinoma After Radical Resection From Retrospective Multi-Center Analysis (YPB-003). Co-author DOI 10.1002/cam4.70647↗
  4. Multicenter Prospective Cohort Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer (YPB-001). Co-author DOI 10.1097/mpa.0000000000002323↗
  5. Therapeutic Efficacy of IL7/CCL19-Expressing CAR-T Cells in Intractable Solid Tumor Models of Glioblastoma and Pancreatic Cancer. Co-author DOI 10.1158/2767-9764.crc-24-0226↗
  6. Safety and Feasibility of Neoadjuvant-Modified FOLFIRINOX in Elderly Patients with Pancreatic Cancer. Co-author DOI 10.3390/cancers16142522↗
  7. [A Case of Pancreatic Cancer with Concomitant Pancreatic Metastasis of Renal Cell Carcinoma]. Co-author PMID 39948974↗
  8. The tumor immune microenvironment in pancreatic cancer and its potential in the identification of immunotherapy biomarkers. Co-author DOI 10.1080/14737159.2023.2281482↗
  9. Efficacy of Staging Laparoscopy in Patients With Pancreatic Cancer: A Single Center Prospective Cohort Study. Co-author DOI 10.21873/invivo.13380↗
  10. Hepatic artery resection and reconstruction using the right gastroepiploic artery during pancreaticoduodenectomy in advanced pancreatic cancer. Co-author DOI 10.1007/s00423-021-02120-0↗
  11. Novel Indications for Surgical Resection of Metachronous Lung Metastases From Pancreatic Cancer After Curative Resection. Co-author DOI 10.1097/mcg.0000000000000551↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yoshitaro Shindo · 10 shared papers, 2017–2026 · strength 1.87
  2. Hiroaki Nagano · 9 shared papers, 2017–2026 · strength 1.67
  3. Hiroto Matsui Matsui · 9 shared papers, 2017–2026 · strength 1.64
  4. Tatsuya Ioka · 7 shared papers, 2023–2026 · strength 1.44
  5. Ryouichi Tsunedomi · 4 shared papers, 2023–2026 · strength 0.94
  6. Yusaku Watanabe · 3 shared papers, 2024–2026 · strength 0.64
  7. Hidenori Takahashi · 3 shared papers, 2024–2026 · strength 0.64
  8. Hiroaki Nagano · 2 shared papers, 2023–2024 · strength 0.43
  9. Nobuaki Suzuki · 3 shared papers, 2017–2023 · strength 0.37
  10. Taro Takami · 2 shared papers, 2024–2025 · strength 0.37
  11. Hidekazu Tanaka · 2 shared papers, 2024–2025 · strength 0.37
  12. Kimikazu Hamano · 2 shared papers, 2024–2025 · strength 0.37
  13. Mari Nabeya · 1 shared paper, 2026 · strength 0.26
  14. Koji Tamada · 1 shared paper, 2024 · strength 0.23
  15. Keisuke Ohta · 1 shared paper, 2024 · strength 0.23
  16. Akira Yakabe · 1 shared paper, 2024 · strength 0.20
  17. Katsuyoshi Ito · 1 shared paper, 2024 · strength 0.17
  18. Satoshi Matsukuma · 1 shared paper, 2021 · strength 0.13
  19. Tomio Ueno · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.